3M FLUOROCHEMICAL SUBMISSIONS February, 2002 - May, 2004 INDEX OF 3M'S 2002-2004 AR-226 DOCKET SUBMISSIONS BY DATE Back to Menu February 2004 Click on Study Title to View Report February 24, 2004 February 24, 2004 Submission Cover Letter Final Report, Pharmacokinetic Study of Perfluorooctanesulfonyl Fluoride (POSF) Following a Single Oral Gavage Dose in Rats.

3M FLUOROCHEMICAL SUBMISSIONS February, 2002 - May, 2004 INDEX OF 3M'S 2002-2004 AR-226 DOCKET SUBMISSIONS BY DATE Back to Menu May 2004 Click on Study Title to View Report May 11, 2004 May 11, 2004 Submission Cover Letter Page 1, 2, 3, 4, 5 Final Report, Descriptive Analysis of Serum Perfluorooctanoate (PFOA) and Perfluorooctanesulfonate (PFOS) Concentrations of Antwerp Employee Participants from the 2003 Fluorochemical Medical Surveillance Program, 3M Medical Department, August 14, 2003.

TOXICITY TO TERRESTRIAL PLANTS TEST SUBSTANCE Identity: P e rflu o ro o cta n e su lfo n a te ; m ay also be referred to as PFO S or FC-95. (1-O ctanesulfonic acid, 1,1,2,2,3,3,4,4,5,5,6,6,7,7,8,8,8heptadecafluoro-, potassium salt, CAS # 2795-39-3) Remarks: The te st su b sta n ce is a w h ite pow der.

3M Company Page 1 of 121 FINAL REPORT Epidemiology, 220-3W-05 Medical Department 3M Company St.

3M Company EPl-0013 Page lo f 36 FINAL REPORT Epidemiology Medical Department 3M Company S t Paul.

BACK TO MAIN 3M FLUOROCHEMICAL SUBMISSION TOXICOLOGY, EPIDEMIOLOGY AND MEDICAL SURVEILLANCE April 2005 Click on Study Title to View Report April 18, 2005 John L.

AR226-2182 Robert F Pinchot 08/22/2001 12:50 PM To: cc: Subject: Chris E Shoop/AE/DuPont@DuPont, Ta-Wei Fu/SE/DuPont@DuPont, Roger J Zipfel/AE/DuPont@DuPont Debbie J Mulrooney/AE/DuPont@DuPont, Stephen J Gissy/AE/DuPont@DuPont, David M Rurak/AE/DuPont@DuPont APFO Air modeling: Meeting Monday August 27th Chris, Ta-W ei, Roger, Debbie tells me she will have all the information that she needs to run a "final" current state air dispersion model by late this week.

AR226-2190 Debbie J Mulrooney ' 08/27/2001 02:32 PM !

AR226-2211 tt Ron J Buchanan 11/06/2001 07:07 AM To: Roger J Zipfel/AE/DuPont@DuPont ' cc: Robert F Pinchot/DEV/AE/DuPont@DuPont, John A Wilkens/AE/DuPont@DuPont Subject Re: Mulit Media Consent Order APFO data requirements || Thanks for the info Roger, could you send an excel spreadsheet showing the isotherm data and data plots you have??

AR226-2275 Robert F P inchot 04/23/2002 08:14 AM To: George H Senkler_Jr/AE/DuPont@ DuPont cc: Subject: Final Modeling Report G e o rg e , Here is the modeling report.

AR226-2811 DuPont-13788 Trade S ecret Review of Proliferative Lesions of the Exocrine Pancreas in Two Chronic Feeding Studies in Rats with Ammonium Perfluorooctanoate Authors Steven R.

AR226-3144 CONFIDENTIAL SPONSOR Elf Atochem S.A.

Katherine E.

3M General Offices September 21, 2006 3M Center St.

KStaatfhf eVriicneePEre. sRideeendt, Ph.D. 3SMafeEtynOvirpoenramtieonntsal, Health and 96PS50tO.10PBB7ao7uux8ls,h34M33A3N3v13e51n5u1e3, 3B-3u3il3d1ipng. 142-2E-26 %Er'tL-(y707-& 3 72> /tezz -37^6 L# Certified Mail June 6,2007 DEOUW12PSfoaf0Acis0EcuheEPmiPnAaoeegsnfnttnotP-snPoyRlrDllovuoCcatoeinmos2insa0i64nPA46gr2v0eC8ev-0neeA0unn0ettttie1noNr:nWSaencdtiTonox8i(ces) CONTAIN NO CBI 89070000329 9 o ; o o o (T~Y NO CBI f- < Re: TSSulCfoAna8t(ee-)baSsuebdstaanndtiaClaRrbisokxyNlioct-ibcea:seSdupFpluleomroecnhteaml tiocaDlsocket No. 8EHQ-0598-373; To whom it may concern: t3oodddlhiMobeufmyftsjrsereiiepontrrcseemrigtddicionvi,egfnfgenteuer0tsafon.ltt1oyncafhlsttetloriiihoeooereiwcnnnsf0efti.sasine3vettncguufemdtfddsdeeyyglxcoaa/ptwcikfdnootgeaarsnrx/satudaipfmorttatoosenyofsciodutdnaooefrinandrettldehdaornreuscmenohctpmititomvonerwoirdeeatttsyethtofeudheranrloerntnamptatdiponoltohhtaaPtaaeaennnFsbndsyhOoititiirununSgaamelaehlodtueo(inupgrsofoatreanPittrvdnaoFfiaogllxnOugstigeohcemSe)ryoeaostrdfloftooefaecie1stivditc.n.oa0etdsnlnomuitenapcatgesnmuF/udskn1el.g-fenlgoa/uEtdencarxantoalaypettnteoorieoaoxs(untnuPiirclo,roFyenaetOoanftoofSxdvefi)fcPect.sotriFpstyTyOriihnSnaengdat Tom0eamnv.bi1eimdascm,elrveu0roo-ava.sm3rgtacyi,itooanioeontpaervnsildca1pwbl.feau0aeextatemrmatteneimaocrgclynyi/eonk)sn(agrFwwdat/iOtdueoesacrBrnewytee)oee,dpdvfr,aeueatcrrahlfoiaunyonudadrrgtmsometiigindiedcned.dssiis,.stcTtattaaehhtItrinroyytoelrrrenadsoodirioapdddenofisdtsctppiateohortslhunynlsr,csispouitebcurum,roargalelloihiPdnfaceFelnowravOdamceetStlifoiaoougttdpnionhoamrctaintlaaesiyodncsnatnadtbiyyv(ywp,bi(otoaaeLytlrnrea,aDednnla)otengaivp2adnaarl0avell.lnaeupygaeausrueFttineisruaadionnoltpcgvfsdateiTotiaaphosnSanoedHrlaaolletgliveoievcnlaesllso.f FapbfeaoToainfctynabuhntftdtsrneediemPievccribnmNrenittaucvtisgteyDoywteesamwndrcebinao1enoorlilar3reenrutel,yochntnmtbho1eltroaissa7eamnFPen,aoladreFiitg2tnvtmhs1OeemmdaesdietSroenaainio.talrtnoedttennh6sMeswbape1atclaroi.garaatn1beshteird.eTtnaa0tnraiPsthfcnatwnemFeeeltademrarOeigly-enliw/raSgbkdewptlho.ehgelaatdaiesey/,rgItdryanedehln(amedwPutuyannreNamdeeogigttnfditeDbrfghcagiroeethh,)tsicutrt,otaoaht1spnsonsire7ntwg,fa,owampetsrnrewhasirtrecdelethemensoi-trenhetmdohrareTeoetnaiwposncfbSdaaprerbi/FHnreortoaea]ueancrdilsoamnsatnpetiritnciovvdooantroiehslegPtwptetnyayh-FsrtesirweeotOeiosohpnsecirtSuid,ahoensft-nteisniergattawiechmotntllliaueetigasaamnssrrttlelrtidepesemcpdeaesenahann.rxiltcrinidvsoalcsPagititdioraotnFigoasonmliaOnocbnntnwibragimSfyolalueyii-lcetnrlrdoyaaetnedgorh,tnltrosuaavioclwanretntaeueygtaaegwpederifrimr.nnfeennleiraoetanechlvltgtoeeerld / 3S| P-2 t1h.0e hmiggh/kegs/tddaoysedocshaogseengrwouasp arpelpartoivperitaoteclyonetfrfoelcstidvueriinngptrhoedulaccitnagtioann pefefreioctd.inTmhaisteirnndailcraattess. that tAohnletgho8oi(une)gghdwotohcrkekseetbadysaUtaa.Ssdu.opEpnPloeAtmmteoeneattstsothepsesre`fsvluuiboosurtosacnshutiebamml iricissaskliso'.nresT.phoerrtienfogrteh,rwesehoarlde,pwlaecirnegcotghneiszeerethseults in Trwehiplelorbinte-ilsfiofperewnpaodrridntiegodnintoocfltuhthseiiosEnsPtoAufdoryensicsuelctiostmfirsporlmeecteeainavanelddy.saisdroaffpt hfianraml arecpookrint ehtaics bsaemenplperso.duTcheed.finTahlerefpinoarlt (I6f5y1o)u7h3a7v-e13a7n4y.questions or need additional information, please contact Deanna Luebker at Sincerely, ^ KStaatfhfeVriincee EP.reRseideednt, Environmental, Health and Safety Operations